Naveruclif

Medicinal product

(Invented) name

Naveruclif

Active substance (s)

Paklitakselis

Strength

5 mg/ml

Pharmaceutical form

milteliai dispersinei infuzijai

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01CD01, Paclitaxel

Marketing authorisation holder

Accord Healthcare B.V., Nyderlandai

Date of authorisation

2024-01-05

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for dispersion for infusion	1 ml
Paklitakselis	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112508	98628	1098628	flakonas	N1		Receptinis	EU/1/23/1778/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-01-05	Registruotas